Emergence of Hemagglutinin Mutations During the Course of Influenza Infection

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Cushing, Anna ^a   Kamali, Amanda ^a   Winters, Mark ^b   Hopmans, Erik S ^a   Bell, John M ^a   Grimes, Susan M ^a   Xia, Li C ^a   Zhang, Nancy R ^c   Moss, Ronald B ^d   Holodniy, Mark ^a,b   Ji, Hanlee P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Ansun BioPharma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRAL PROTEIN;

ADULT; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MUTATION; PHASE 2 CLINICAL TRIAL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VIROLOGY; YOUNG ADULT;

ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; VACCINATION; VIRAL PROTEINS; YOUNG ADULT;

EID: 84946606376     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16178     Document Type: Article

References (20)

1. WHO. Influenza (Seasonal) Fact sheet N211. Vol. 2013 (2009).
2. Soundararajan, V. et al. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nature biotechnology 27, 510-3 (2009).
3. Xu, J. et al. [Cloning and sequencing full-length genome of H5N1 avian influenza A virus and molecular evolution analysis of HA gene]. Wei sheng yan jiu = Journal of hygiene research 40, 631-4 (2011).
4. Kamali, A. & Holodniy, M. Influenza treatment and prophylaxis with neuraminidase inhibitors: a review. Infection and drug resistance 6, 187-98 (2013).
5. Dugan, V. G., Saira, K. & Ghedin, E. Large-scale sequencing and the natural history of model human RNA viruses. Future Virol 7, 563-573 (2012).
6. Ghedin, E. et al. Mixed infection and the genesis of influenza virus diversity. J Virol 83, 8832-41 (2009).
7. Furuse, Y. et al. Occurrence of mixed populations of influenza A viruses that can be maintained through transmission in a single host and potential for reassortment. J Clin Microbiol 48, 369-74 (2010).
8. Flaherty, P. et al. Ultrasensitive detection of rare mutations using next-generation targeted resequencing. Nucleic Acids Res 40, e2 (2012).
9. Cushing, A., Flaherty, P., Hopmans, E., Bell, J. M. & Ji, H. P. RVD: a command-line program for ultrasensitive rare single nucleotide variant detection using targeted next-generation DNA resequencing. BMC Res Notes 6, 206 (2013).
10. Guindon, S., Lethiec, F., Duroux, P. & Gascuel, O. PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 33, W557-9 (2005).
11. Criscuolo, A. morePhyML: improving the phylogenetic tree space exploration with PhyML 3. Mol Phylogenet Evol 61, 944-8 (2011).
12. Choi, Y., Sims, G. E., Murphy, S., Miller, J. R. & Chan, A. P. Predicting the functional effect of amino acid substitutions and indels. PLoS One 7, e46688 (2012).
13. Sun, Y. et al. In silico characterization of the functional and structural modules of the hemagglutinin protein from the swineorigin influenza virus A (H1N1)-2009. Sci China Life Sci 53, 633-42 (2010).
14. Xu, R. et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357-60 (2010).
15. Munoz, E. T. & Deem, M. W. Epitope analysis for influenza vaccine design. Vaccine 23, 1144-1148 (2005).
16. Skowronski, D. M. et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Euro Surveill 20, e18 (2015).
17. Moss, R. B. et al. A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. J Infect Dis 206, 1844-51 (2012).
18. Stevens, J. et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. Journal of molecular biology 355, 1143-55 (2006).
19. Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Briefings in bioinformatics 14, 178-92 (2013).
20. Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. in Genome Research 22 568-576 (2012).